Genome Medicine · Published 2018-12-01 · Available online 24 Apr 2018 · Journal article · DOI 10.1186/s13073-018-0543-4 · Cited by 102 (Crossref)
Editorial summary CRISPR–Cas systems have provided revolutionary tools for genome editing. The discovery of Cas proteins with alternative activities has now enabled sensitive and robust tools for detecting nucleic acids. Recent reports harnessing these new CRISPR–Cas technologies display their potential for providing low-cost and practical diagnostic tools for pathogen and disease detection.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Sashital, D. (2018). Pathogen detection in the CRISPR–Cas era. Genome Medicine. https://doi.org/10.1186/s13073-018-0543-4